Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy—results from the ACOSOG Z1041 (Alliance) trial
Titel:
Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy—results from the ACOSOG Z1041 (Alliance) trial
Auteur:
Lesurf, R. Griffith, O.L. Griffith, M. Hundal, J. Trani, L. Watson, M.A. Aft, R. Ellis, M.J. Ota, D. Suman, V.J. Meric-Bernstam, F. Leitch, A.M. Boughey, J.C. Unzeitig, G. Buzdar, A.U. Hunt, K.K. Mardis, E.R.